RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$75.19M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
RetinalGenix Technologies Inc.RetinalGenix Technologies Inc.-36-96%--
$-0.00

Current Fair Value

100.1% downside

Overvalued by 100.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$75.19 Million
Enterprise Value$75.24 Million
Earnings per Share$-0.13
Beta-3.28
Outstanding Shares18,808,072

Return

Return on Equity96.34%ROE
Return on Assets-44961.76%
Return on Invested Capital-23.61%

Valuation & Multiples

P/E Ratio-36.04P/E Ratio
PEG151PEG
Price to Sales-Price to Sales
Price to Book Ratio-3.99Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT157.29
Enterprise Value to Net Income-39
Total Debt to Enterprise0
Debt to Equity-0.03Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About RetinalGenix Technologies Inc.

0
CEO: Jerry Katzman

RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a ra...